Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Pulmonary complications

E Vichinsky¹, L Styles

¹Division of Hematology/Oncology, Children's Hospital Oakland, California, USA.

Hematology/Oncology Clinics of North America

|December 1, 1996

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.

Blood advances·2020

Same author

Application of an expanded multiplex genotyping assay for the simultaneous detection of Hemoglobin Constant Spring and common deletional alpha-thalassemia mutations.

International journal of laboratory hematology·2009

Same author

An expanded Transactional Stress and Coping Model for siblings of children with sickle cell disease: family functioning and sibling coping, self-efficacy and perceived social support.

Child: care, health and development·2008

Same author

Prevalence of fractures among the Thalassemia syndromes in North America.

Bone·2005

Same author

The new SQUID biosusceptometer at Oakland: first year of experience.

Neurology & clinical neurophysiology : NCN·2005

Same author

Nesidioblastosis in sickle cell disease.

Pediatric pathology & molecular medicine·2003

Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026

Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026

Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026

Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026

Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026

Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026

See all related articles

Acute chest syndrome management is evolving with better understanding of its causes. Personalized treatment and monitoring are key, with new therapies offering future hope for reducing patient suffering.

Area of Science:

Hematology
Pulmonary Medicine
Critical Care Medicine

Background:

Acute chest syndrome (ACS) is a leading cause of morbidity and mortality in specific patient populations.
The underlying causes and mechanisms of ACS are increasingly understood, driving changes in clinical practice.

Purpose of the Study:

To outline current best practices for managing patients with acute chest syndrome.
To highlight the importance of individualized treatment strategies based on patient presentation and disease course.

Main Methods:

Review of current literature and clinical guidelines.
Emphasis on aggressive patient evaluation and continuous monitoring.
Discussion of tailored therapeutic approaches.

Related Experiment Videos

Main Results:

Management strategies for ACS are adapting to new etiological and pathophysiological insights.
Personalized care, including vigilant monitoring and individualized treatment, is crucial for optimal patient outcomes.

Conclusions:

The evolving understanding of ACS necessitates dynamic management approaches.
Future therapeutic advancements hold significant potential for mitigating ACS-related complications and improving patient prognosis.